Literature DB >> 31524163

Predictors of Cognitive Impairment After Stroke: A Prospective Stroke Cohort Study.

Meng-Yuan Ding1, Yi Xu1, Ying-Zhe Wang1, Pei-Xi Li1, Yi-Ting Mao1, Jin-Tai Yu1, Mei Cui1, Qiang Dong1,2.   

Abstract

BACKGROUND: Post-stroke cognitive impairment (PSCI) significantly affects stroke survivors' quality of life and rehabilitation. A risk model identifying cognitive decline at admission would help to improve early detection and management of post-stroke patients.
OBJECTIVE: To develop a new clinical risk score for ischemic stroke survivors in predicting 6-12 months PSCI.
METHODS: We prospectively enrolled 179 patients diagnosed with acute ischemic stroke within a 7-day onset. Data were analyzed based on baseline demographics, clinical risk factors, and radiological parameters. Logistic regression and area under the receiver operating curve (AUROC) were used to evaluate model efficiency.
RESULTS: One hundred forty-five subjects completed a 6-12-month follow-up visit, and 77 patients (53.1%) were diagnosed with PSCI. Age (β= 0.065, OR = 1.067, 95% CI = 1.016-1.120), years of education (β= -0.346, OR = 0.707, 95% CI = 0.607-0.824), periventricular hyperintensity grading (β= 1.253, OR = 3.501, 95% CI = 1.652-7.417), diabetes mellitus (β= 1.762, OR = 5.825, 95% CI = 2.068-16.412), and the number of acute nonlacunar infarcts (β= 0.569, OR = 1.766, 95% CI = 1.243-2.510) were independently associated with 6-12 month PSCI, constituting a model with optimal predictive efficiency (AUC = 0.884, 95% CI = 0.832-0.935).
CONCLUSIONS: The optimized risk model was effective in screening stroke survivors at high risk of developing 6-12 months PSCI in a simple and pragmatic way. It could be a potential tool to identify patients with a high risk of PSCI at an early stage in clinical practice after further independent external cohort validation.

Entities:  

Keywords:  Cognitive dysfunction; cohort studies; predictors; stroke

Year:  2019        PMID: 31524163     DOI: 10.3233/JAD-190382

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

1.  Obstructive sleep apnea is associated with cognitive impairment in minor ischemic stroke.

Authors:  Ruo-Lin Zhu; Chao Ouyang; Ruo-Lin Ma; Kai Wang
Journal:  Sleep Breath       Date:  2022-03-19       Impact factor: 2.816

2.  European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.

Authors:  Terence J Quinn; Edo Richard; Yvonne Teuschl; Thomas Gattringer; Melanie Hafdi; John T O'Brien; Niamh Merriman; Celine Gillebert; Hanne Huyglier; Ana Verdelho; Reinhold Schmidt; Emma Ghaziani; Hysse Forchammer; Sarah T Pendlebury; Rose Bruffaerts; Milija Mijajlovic; Bogna A Drozdowska; Emily Ball; Hugh S Markus
Journal:  Eur Stroke J       Date:  2021-10-08

3.  Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study.

Authors:  Li-Kai Huang; Shu-Ping Chao; Chaur-Jong Hu; Li-Nien Chien; Hung-Yi Chiou; Yu-Chun Lo; Yi-Chen Hsieh
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.702

4.  Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry.

Authors:  Yongjun Wang; Xiaoling Liao; Chunxue Wang; Ning Zhang; Lijun Zuo; Yang Yang; Yuesong Pan; Xianglong Xiang; Jing Jing; Xia Meng; Xingquan Zhao; Yilong Wang; Jiong Shi; Hao Li
Journal:  Stroke Vasc Neurol       Date:  2020-07-13

Review 5.  Prognostic rules for predicting cognitive syndromes following stroke: A systematic review.

Authors:  Bogna A Drozdowska; Kris McGill; Michael McKay; Roisin Bartlam; Peter Langhorne; Terence J Quinn
Journal:  Eur Stroke J       Date:  2021-02-23

6.  Efficacy and safety of acupuncture combined with Chinese herbal medicine traditional Chinese medicine for poststroke cognitive impairment: A protocol for a systematic review and meta-analysis.

Authors:  Ying Wang; Sha Guo; Meng-Lu Xiao; Hong Zhang
Journal:  Medicine (Baltimore)       Date:  2022-03-04       Impact factor: 1.817

Review 7.  Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Xueming Fan; Wei Shen; Liuding Wang; Yunling Zhang
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

8.  Factors Influencing Post-Stroke Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.

Authors:  Zhao-Yin Ma; Yong-Ya Wu; Hong-Yin-Long Cui; Guang-Yan Yao; Hong Bian
Journal:  Clin Interv Aging       Date:  2022-04-29       Impact factor: 3.829

9.  Reduced thiamine is a predictor for cognitive impairment of cerebral infarction.

Authors:  Liang Feng; Weilei He; Guiqian Huang; Shasha Lin; Chengxiang Yuan; Haoran Cheng; Jincai He; Yiming Liu
Journal:  Brain Behav       Date:  2020-08-05       Impact factor: 2.708

10.  Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months.

Authors:  Yi Dong; Mengyuan Ding; Mei Cui; Min Fang; Li Gong; Zhuojun Xu; Yue Zhang; Xiuzhe Wang; Xiaofeng Xu; Xueyuan Liu; Gang Li; Yuwu Zhao; Qiang Dong
Journal:  Aging (Albany NY)       Date:  2021-09-10       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.